Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
Abroad (travel likely)RecruitingPHASE2
Conditions
Metastatic Chondrosarcoma · Locally Advanced Chondrosarcoma · Metastatic Sinonasal Adenocarcinoma · Locally Advanced Sinonasal Adenocarcinoma · Metastatic Large-cell Neuroendocrine Carcinoma · Locally Advanced Large-cell Neuroendocrine Carcinoma · Metastatic Olfactory Neuroblastoma · Locally Advanced Olfactory Neuroblastoma · Metastatic Sinonasal Undifferentiated Carcinoma · Locally Advanced Sinonasal Undifferentiated Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (National Cancer Institute Referral Office) · ncimo_referrals@mail.nih.gov · 888-624-1937
Study leads
Charalampos Floudas, M.D.
Principal Investigator
National Cancer Institute (NCI)